Stock Events

Stock Events

Stimcell Energetics 

$0.29
0
+$0+0% Tuesday 16:22

Statistics

Day High
0.29
Day Low
0.29
52W High
0.64
52W Low
0.22
Volume
1,440
Avg. Volume
-
Mkt Cap
6.06M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-1.13MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow STME. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Dexcom
DXCM
Mkt Cap23.67B
Dexcom, Inc. specializes in glucose monitoring systems, competing in the medical device sector focused on diabetes management, similar to Cell MedX's focus.
Tandem Diabetes Care
TNDM
Mkt Cap1.33B
Tandem Diabetes Care, Inc. provides innovative insulin delivery systems, directly competing in the diabetes care market where Cell MedX operates.
Insulet
PODD
Mkt Cap12.12B
Insulet Corporation manufactures insulin pump technology, aligning with diabetes management solutions, a field relevant to Cell MedX's interests.
Abbott Laboratories
ABT
Mkt Cap155.82B
Abbott Laboratories offers a broad range of medical devices including glucose monitoring systems, competing in the same healthcare segment as Cell MedX.
Medtronic
MDT
Mkt Cap102.71B
Medtronic plc provides medical technologies, services, and solutions including diabetes management products, directly competing with Cell MedX's offerings.
Senseonics
SENS
Mkt Cap213.2M
Senseonics Holdings, Inc. focuses on the development of glucose monitoring systems, which is a direct competition to Cell MedX's diabetes-related technologies.
Novo Nordisk
NVO
Mkt Cap194.57B
Novo Nordisk A/S, a global healthcare company, focuses on diabetes care products, competing in the same therapeutic area as Cell MedX.
Sanofi
SNY
Mkt Cap110.4B
Sanofi S.A. engages in the development and marketing of therapeutic solutions including diabetes care, which competes with Cell MedX's market.
Merck
MRK
Mkt Cap277.02B
Merck & Co., Inc. provides healthcare solutions including diabetes management drugs and therapies, competing in the broader diabetes care market relevant to Cell MedX.

About

StimCell Energetics Inc., a biotech company, discovers, develops, and commercializes therapeutic and non-therapeutic products for patients with diabetes, Parkinson's disease, high blood pressure, neuropathy, and kidney functions in the United States. It develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for three pre-programmed microcurrent algorithms, including wellness, pain management, and dual. The company also develops eBalance Home and eBalance Pro System for temporary relief of shoulder, waist, back, neck, arms, and legs. The company was formerly known as Cell MedX Corp. and changed its name to StimCell Energetics Inc. in November 2024. StimCell Energetics Inc. was incorporated in 2010 and is headquartered in Vancouver, Canada.
Show more...
CEO
Mr. David M. Jeffs
Employees
1
Country
United States
ISIN
US15115X2062

Listings

OTC Link
US
STME

0 Comments

Share your thoughts

FAQ

What is Stimcell Energetics stock price today?▼
The current price of STME is $0.29 USD — it has increased by +0% in the past 24 hours. Watch Stimcell Energetics stock price performance more closely on the chart.
What is Stimcell Energetics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Stimcell Energetics stocks are traded under the ticker STME.
Is Stimcell Energetics stock price growing?▼
STME stock has fallen by -1.69% compared to the previous week, the month change is a -3.33% fall, over the last year Stimcell Energetics has showed a +20.83% increase.
What is Stimcell Energetics market cap?▼
Today Stimcell Energetics has the market capitalization of 6.06M
What is Stimcell Energetics revenue for the last year?▼
Stimcell Energetics revenue for the last year amounts to 0 USD.
What is Stimcell Energetics net income for the last year?▼
STME net income for the last year is -1.13M USD.
How many employees does Stimcell Energetics have?▼
As of May 06, 2026, the company has 1 employees.
In which sector is Stimcell Energetics located?▼
Stimcell Energetics operates in the Other sector.
When did Stimcell Energetics complete a stock split?▼
The last stock split for Stimcell Energetics was on November 05, 2024 with a ratio of 1:15.
Where is Stimcell Energetics headquartered?▼
Stimcell Energetics is headquartered in Vancouver, United States.